Khountham S, Shindiapina P, Mo X, Lachowiez C, Wiczer T, Mousa L, Rogers KA, Andritsos LA, Woyach JA, Byrd JC, Spurgeon SE, Awan FT
Leuk Lymphoma in press Natural history of noninfectious, ibrutinib-attributable adverse
Natural history of noninfectious, ibrutinib-attributable adverse
events in patients with chronic lymphocytic leukemia.
November 19, 2020 at 12:00 AM